Study eligibility was independently assessed through title, abstract, and full text-screening by two reviewers (A.V.C. and D.D.B.) using a standardised, unblinded approach. Studies were screened independently, and any disagreements were resolved at the end of each stage by A.V.C. and D.D.B., with any persistent disagreements resolved by a third reviewer (S.C.). If insufficient information was provided, the author(s) of the identified studies were contacted by email to provide relevant information for eligibility assessment.

The first reviewer (A.V.C.) used a standardised form to extract data using an adapted version of the Cochrane data collection form for intervention reviews: RCTs and non-RCTs [41]. The following data were extracted: country of study, sample demographics (e.g., age, sex, ethnicity, weight status, socioeconomic status), study characteristics (e.g., design, description, no. of study arms, length, follow-up period(s), setting), measurement characteristics (e.g., measurement tool, reported outcome), device characteristics (e.g., device brand and model), and study results.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.